CA2837341C - Method of determining vasoreactivity using inhaled nitric oxide - Google Patents

Method of determining vasoreactivity using inhaled nitric oxide Download PDF

Info

Publication number
CA2837341C
CA2837341C CA2837341A CA2837341A CA2837341C CA 2837341 C CA2837341 C CA 2837341C CA 2837341 A CA2837341 A CA 2837341A CA 2837341 A CA2837341 A CA 2837341A CA 2837341 C CA2837341 C CA 2837341C
Authority
CA
Canada
Prior art keywords
patient
vasoreactivity
determining
nitric oxide
inhaled nitric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2837341A
Other languages
English (en)
French (fr)
Other versions
CA2837341A1 (en
Inventor
Tammy WATTS
Robert F. Roscigno
David H. Fine
Lewis J. Rubin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vero Biotech Inc
Original Assignee
Vero Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vero Biotech Inc filed Critical Vero Biotech Inc
Publication of CA2837341A1 publication Critical patent/CA2837341A1/en
Application granted granted Critical
Publication of CA2837341C publication Critical patent/CA2837341C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026—Measuring blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Anesthesiology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Physiology (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2837341A 2011-05-27 2012-05-24 Method of determining vasoreactivity using inhaled nitric oxide Active CA2837341C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161490929P 2011-05-27 2011-05-27
US61/490,929 2011-05-27
PCT/US2012/039401 WO2012166534A1 (en) 2011-05-27 2012-05-24 Method of determining vasoreactivity using inhaled nitric oxide

Publications (2)

Publication Number Publication Date
CA2837341A1 CA2837341A1 (en) 2012-12-06
CA2837341C true CA2837341C (en) 2021-10-19

Family

ID=47259769

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2837341A Active CA2837341C (en) 2011-05-27 2012-05-24 Method of determining vasoreactivity using inhaled nitric oxide

Country Status (6)

Country Link
US (1) US11154210B2 (enExample)
EP (1) EP2713723B1 (enExample)
JP (3) JP2014527025A (enExample)
AU (1) AU2012262534B2 (enExample)
CA (1) CA2837341C (enExample)
WO (1) WO2012166534A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618594B2 (en) 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
EP2724742B1 (en) * 2004-08-18 2017-11-01 Geno LLC Conversion of nitrogen dioxide (no2) to nitric oxide (no)
WO2009097343A1 (en) 2008-01-28 2009-08-06 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
US8607785B2 (en) 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
WO2010151505A1 (en) 2009-06-22 2010-12-29 Geno Llc Nitric oxide therapies
CA2837341C (en) 2011-05-27 2021-10-19 Geno Llc Method of determining vasoreactivity using inhaled nitric oxide
EP2951968B1 (en) 2014-04-15 2018-07-18 CommScope Technologies LLC Wideband remote unit for distributed antenna system
AU2017218391B2 (en) * 2016-02-12 2022-11-24 Mallinckrodt Pharmaceuticals Ireland Limited Use and monitoring of inhaled nitric oxide with left ventricular assist devices
WO2018157172A1 (en) 2017-02-27 2018-08-30 Third Pole, Inc. Systems and methods for generating nitric oxide
US10328228B2 (en) 2017-02-27 2019-06-25 Third Pole, Inc. Systems and methods for ambulatory generation of nitric oxide
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
US11672938B1 (en) 2018-07-18 2023-06-13 Vero Biotech LLC Start-up protocols for nitric oxide delivery device
CA3116166A1 (en) * 2018-10-12 2020-04-16 Sanotize Research And Development Corp. Gas-evolving compositions and container and delivery systems
JP2022533628A (ja) 2019-05-15 2022-07-25 サード ポール，インコーポレイテッド 一酸化窒素生成用電極
US11479464B2 (en) 2019-05-15 2022-10-25 Third Pole, Inc. Systems and methods for generating nitric oxide
WO2020232414A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Architectures for production of nitric oxide
EP4069069A4 (en) 2020-01-11 2024-07-03 Third Pole, Inc. SYSTEMS AND METHODS FOR NITROGEN OXIDE PRODUCTION WITH HUMIDITY CONTROL
EP4167920A4 (en) 2020-06-18 2024-06-12 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
WO2022082072A1 (en) 2020-10-16 2022-04-21 Third Pole, Inc. Nitric oxide generation process controls
US11975139B2 (en) 2021-09-23 2024-05-07 Third Pole, Inc. Systems and methods for delivering nitric oxide

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6758214B2 (en) 2000-01-28 2004-07-06 Cyterra Corporation Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment
CA2459891C (en) 2001-09-05 2014-02-04 Cyterra Corporation Method and apparatus for nitric oxide generation
US7618594B2 (en) 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
EP2724742B1 (en) 2004-08-18 2017-11-01 Geno LLC Conversion of nitrogen dioxide (no2) to nitric oxide (no)
CA2588994A1 (en) * 2004-12-08 2006-06-15 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of pulmonary hypertension of the newborn
WO2007087575A2 (en) * 2006-01-24 2007-08-02 University Of Chicago Compositions and methods for treating pulmonary hypertension
CA2681308C (en) 2007-03-23 2015-11-24 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
WO2009097343A1 (en) 2008-01-28 2009-08-06 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
JP6058888B2 (ja) 2008-07-24 2017-01-11 ゲノ エルエルシー 患者における心臓の病気の診断及び治療方法
US10960168B2 (en) 2008-08-21 2021-03-30 Vero Biotech LLC Delivery of high concentration nitric oxide
US10780241B2 (en) 2008-08-21 2020-09-22 Vero Biotech LLC Devices and methods for minimizing and treating high-altitude sickness
US8607785B2 (en) 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
US8701657B2 (en) 2008-08-21 2014-04-22 Geno Llc Systems for generating nitric oxide
US8173072B2 (en) 2008-09-22 2012-05-08 Geno Llc Conversation of nitrogen dioxide (NO2) to nitric oxide (NO)
WO2010151505A1 (en) 2009-06-22 2010-12-29 Geno Llc Nitric oxide therapies
CA3130908A1 (en) * 2009-06-30 2010-12-30 Mallinckrodt Hospital Products IP Limited Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
US20120093948A1 (en) * 2009-11-20 2012-04-19 Fine David H Nitric Oxide Treatments
US8646445B2 (en) 2009-11-20 2014-02-11 Geno Llc Nitric oxide delivery system
WO2011137122A1 (en) 2010-04-26 2011-11-03 Geno Llc Nitrosyl special connector
WO2011137124A1 (en) 2010-04-26 2011-11-03 Geno Llc Delivery of ultra pure nitric oxide (no)
USD688352S1 (en) 2010-04-27 2013-08-20 Geno Llc Female gas connector
USD679366S1 (en) 2010-04-27 2013-04-02 Geno Llc Male gas connector
JP2014506872A (ja) * 2010-12-03 2014-03-20 ゲノ エルエルシー 一酸化窒素治療
CA2833914A1 (en) * 2011-05-10 2012-11-15 Universite Laval Methods for the treatment and diagnostic of pulmonary arterial hypertension
CA2837341C (en) 2011-05-27 2021-10-19 Geno Llc Method of determining vasoreactivity using inhaled nitric oxide
EP3209360B1 (en) 2014-10-20 2022-12-07 VERO Biotech LLC Nitrogen dioxide storage cassette

Also Published As

Publication number Publication date
JP2014527025A (ja) 2014-10-09
EP2713723A1 (en) 2014-04-09
US11154210B2 (en) 2021-10-26
CA2837341A1 (en) 2012-12-06
JP2017165731A (ja) 2017-09-21
AU2012262534A1 (en) 2013-12-12
WO2012166534A1 (en) 2012-12-06
EP2713723A4 (en) 2015-03-25
US20130309328A1 (en) 2013-11-21
EP2713723B1 (en) 2018-09-12
JP2019131556A (ja) 2019-08-08
AU2012262534B2 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
CA2837341C (en) Method of determining vasoreactivity using inhaled nitric oxide
AU2018201942B2 (en) Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
IN2014KN00996A (enExample)
MX2017014338A (es) Seleccion dirigida de pacientes para el tratamiento con derivados de cortistatina.
HK1208629A1 (en) Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency
WO2012081898A3 (ko) 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
HK1198869A1 (en) Combination treatments for hepatitis c
EP3208615A3 (en) Uses of labeled hsp90 inhibitors
EP4512470A3 (en) Methods of treating heart failure with cardiac sarcomere activators
WO2012158437A3 (en) Cannula apparatus and ventricular assist systems using the cannula apparatus
PH12013500411A1 (en) Treatment of myocardial infarction using tgf - beta antagonists
TN2016000083A1 (en) Methods and tools relating to the administration of contrast medium
WO2012058585A3 (en) Treatment of heart failure with natriuretic peptides
MX341050B (es) Metodos para tratar infeccion viral respiratoria.
MX354981B (es) Medicamento para tratamiento terapeutico y/o mejoramiento de sepsis.
MX2013007055A (es) Derivados de sanglifehrina y metodos para su produccion.
WO2015066664A3 (en) Compositions and methods for administration of an enzyme to a subject's airway
WO2012040444A3 (en) Treatment of patients with incipient alzheimer's disease
WO2012146736A8 (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
UA64830U (ru) Способ лечения больных гастроезофагеальной рефлюксной болезнью в сочетании с хроническим обструктивным заболеванием легких
EP4410368A3 (en) Promoting lung growth
RU2011108787A (ru) Способ лечения больных красным плоским лишаем слизистой полости рта
UA53602U (ru) Способ возмещения кровопотери при политравме в условиях догоспитального этапа
UA62741U (ru) Способ профилактики респираторных осложнений после операции на легких и плевре с разными видами торакопластики
Liu Digestive tract haemorrhage in an elderly patient: case report

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20161219